Viewing Study NCT05899777



Ignite Creation Date: 2024-05-06 @ 7:06 PM
Last Modification Date: 2024-10-26 @ 3:00 PM
Study NCT ID: NCT05899777
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-06-12
First Post: 2023-04-17

Brief Title: Intervention Effect of Yizhi Baduanjin on Patients With Mild Cognitive Impairment
Sponsor: Shanghai University of Traditional Chinese Medicine
Organization: Shanghai University of Traditional Chinese Medicine

Study Overview

Official Title: Research Development and Promotion of the Service Package of Yizhi Baduanjin for Mild Cognitive Impairment
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: With mild cognitive impairment MCI as the research object the intervention effect of Yizhi Baduanjin on mild cognitive impairment was evaluated by using the Montreal Cognitive Assessment MoCA scale human-computer interactive electronic cognitive function score multi-measure EEG data and other evaluation indicators with the intervention measures of Yizhi Baduanjin created by the Tai Chi Health Center in the early stage This project is based on the preliminary study followed the principles and methods of clinical epidemiology and evidence-based medicine and designed a prospective randomized single-blind parallel controlled trial to make up for the deficiency of existing drugs in the intervention of mild cognitive impairment and to provide evidence for the clinical and community promotion and application of effective and safe traditional Chinese medicine non-pharmaceuticals in the prevention and treatment of mild cognitive impairment
Detailed Description: Mild cognitive impairmentMCI is a critical state between normal aging and dementia with its core symptom being age-related cognitive decline This critical state provides a window of opportunity for preventing Alzheimers disease At present there is a lack of sufficient intervention methods to improve MCI

Yizhi Baduanjin is an adaptation of traditional Baduanjin which is more suitable for middle-aged and elderly people to practice and optimize for improving cognitive function Previous observations and studies have provided some evidence to prove the beneficial effect of Yizhi Baduanjin on MCI

This is a two-group prospective randomized assessor-blinded trial planning to enroll 100 participantsThey will randomly divided into two groups the training group with 50 cases and the control group with 50 cases The training group will receive intervention with the Yizhi Baduanjin and various evaluation indicators will test before and 41224 weeks after the intervention The control group is a waiting control group and after 24 weeks they will continue to learn the Yizhi Baduanjin The control group and the practice group will be tested simultaneously at four time points Finally the intervention effect will be evaluated through inter group and intra group comparisons of test data

The main research purpose is to evaluate the clinical effect of Yizhi Baduanjin on MCIThe secondary research objective is to explore the possible mechanism of Yizhi Baduanjin in improving MCI

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None